Alkyl Amines Chemicals Ltd

AI
Alkyl Amines Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Alkyl Amines Chemicals Ltd

₹ 1,704 -1.00%
22 Oct - close price
alkylamines.com BSE: 506767 NSE: ALKYLAMINE
About

Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.

Key Points

Market Leadership[1] [2]
The company is a global supplier of aliphatic amines, specialty amines, and amine derivatives to the pharmaceutical, agrochemical, water treatment, rubber chemical, and a variety of industries. It holds a leadership position in some of the products in the domestic market.

Website BSE NSE
  • Market Cap ₹ 8,689 Cr.
  • Current Price ₹ 1,704
  • High / Low ₹ 2,115 / 1,212
  • Stock P/E 45.8
  • Book Value ₹ 105
  • Dividend Yield 0.59 %
  • ROCE 41.3 %
  • ROE 41.4 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company has delivered good profit growth of 33.3% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 31.6%
  • Company has been maintaining a healthy dividend payout of 20.3%

Cons

  • Stock is trading at 16.2 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities Nifty Total Market BSE 1000 Nifty Smallcap 500 Nifty Microcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
178 218 213 237 266 235 257 235
141 169 174 199 207 177 184 167
Operating Profit 37 49 39 38 59 58 73 68
OPM % 21% 23% 18% 16% 22% 25% 28% 29%
2 1 3 3 3 2 18 3
Interest 4 4 4 3 4 3 2 2
Depreciation 6 6 6 6 6 7 7 7
Profit before tax 29 41 32 32 52 51 82 61
Tax % 34% 35% 31% 40% 30% -9% 26% 19%
19 27 22 19 37 55 60 49
EPS in Rs 3.78 5.23 4.36 3.71 7.19 10.77 11.85 9.65
Raw PDF
Upcoming result date: 3 November 2026

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
197 214 236 288 366 446 476 484 501 616 846 993
175 183 205 245 308 361 390 393 405 499 682 736
Operating Profit 21 32 31 42 58 85 87 91 95 118 164 257
OPM % 11% 15% 13% 15% 16% 19% 18% 19% 19% 19% 19% 26%
6 6 2 3 1 2 2 3 3 4 6 26
Interest 12 12 10 12 13 12 10 8 8 8 15 10
Depreciation 7 9 9 9 10 10 11 13 14 16 23 27
Profit before tax 8 18 14 24 36 65 67 73 75 97 133 246
Tax % 33% 28% 24% 27% 33% 33% 32% 31% 31% 32% 35% 18%
6 13 14 18 24 43 45 50 52 66 86 201
EPS in Rs 1.10 2.51 2.74 3.45 4.75 8.48 8.85 9.81 10.16 12.94 16.88 39.47
Dividend Payout % 36% 24% 22% 23% 21% 19% 18% 41% 20% 22% 19% 20%
Compounded Sales Growth
10 Years: 17%
5 Years: 16%
3 Years: 26%
TTM: 17%
Compounded Profit Growth
10 Years: 31%
5 Years: 33%
3 Years: 54%
TTM: 120%
Stock Price CAGR
10 Years: 27%
5 Years: -14%
3 Years: -8%
1 Year: -11%
Return on Equity
10 Years: 28%
5 Years: 29%
3 Years: 32%
Last Year: 41%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity Capital 10 10 10 10 10 10 10 10 10 10 10 10
Reserves 56 64 75 88 106 140 174 199 246 299 369 526
133 114 120 123 146 151 135 111 120 181 165 87
54 51 52 60 78 98 93 95 147 159 218 160
Total Liabilities 254 238 258 282 341 398 412 416 522 649 763 783
103 98 98 122 126 155 151 187 220 355 376 423
CWIP 7 14 23 6 9 3 31 16 35 18 43 45
Investments 4 6 10 10 10 10 10 10 12 13 16 0
139 121 126 144 195 230 220 203 256 262 328 315
Total Assets 254 238 258 282 341 398 412 416 522 649 763 783

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
22 43 24 36 22 47 61 101 63 102 144 188
-22 -10 -17 -19 -27 -27 -31 -35 -65 -132 -67 -41
3 -35 -9 -13 5 -13 -36 -68 -2 32 -60 -135
Net Cash Flow 3 -2 -2 4 0 7 -6 -2 -3 2 17 12
Free Cash Flow -1 33 6 21 -2 21 20 66 -1 -33 75 111
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 122% 154% 86% 101% 54% 55% 95% 128% 88% 103% 109% 96%

Ratios

Consolidated / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Debtor Days 70 66 73 77 76 73 76 68 71 73 66 60
Inventory Days 261 180 166 124 132 126 105 92 165 99 88 67
Days Payable 1 0 70 63 69 75 58 63 120 78 104 57
Cash Conversion Cycle 329 246 170 137 139 124 123 96 116 94 51 71
Working Capital Days 182 142 15 10 20 96 93 87 84 76 56 54
ROCE % 11% 15% 12% 17% 20% 28% 25% 25% 24% 25% 28% 41%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export Value (FOB)
Rs Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
R&D Expenditure (% of Turnover)
% ・Standalone data
Total Permanent Employees
count ・Standalone data
Revenue Mix - Aliphatic Amines (% of Revenue)
% ・Standalone data
Revenue Mix - Amine Derivatives (% of Revenue)
% ・Standalone data
Revenue Mix - Specialty Chemicals (% of Revenue)
% ・Standalone data
International Presence (Countries Exported To)
count ・Standalone data
Total Sales Volume
tons ・Standalone data
Installed Capacity by Site
TPA ・Standalone data
Overall Capacity Utilization
% ・Standalone data
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
71.95% 71.95% 71.97% 71.97% 72.01% 72.04% 72.03% 72.03% 72.03% 72.05% 72.04% 72.04%
2.94% 3.04% 3.10% 3.20% 3.23% 3.23% 3.26% 3.44% 3.45% 3.45% 3.50% 3.46%
1.07% 1.11% 1.08% 1.53% 1.77% 2.18% 2.60% 2.88% 3.01% 3.01% 3.10% 3.25%
24.05% 23.91% 23.85% 23.31% 23.00% 22.54% 22.11% 21.66% 21.52% 21.49% 21.36% 21.25%
No. of Shareholders 1,97,1711,92,8851,87,0771,79,0081,74,9271,68,9601,61,0211,53,4511,49,3241,46,0281,42,6251,37,332

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls